<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02169128</url>
  </required_header>
  <id_info>
    <org_study_id>SSTI</org_study_id>
    <nct_id>NCT02169128</nct_id>
  </id_info>
  <brief_title>Severe Soft Tissue Infections: Perspectives of Patients and Significant Others</brief_title>
  <official_title>Severe Soft Tissue Infections: Perspectives of Patients and Significant Others</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Göteborg University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sahlgrenska University Hospital, Sweden</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Karolinska Institutet</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Göteborg University</source>
  <brief_summary>
    <textblock>
      Severe necrotizing soft tissue infection (NSTI), including necrotizing fasciitis, is a life
      threatening infection that spreads quickly to cutis, sub-cutis, fasciae and muscles.
      Approximately 40% of all patients with infections caused by S. Pyogenes develop a
      streptococcal toxic-shock syndrome. In these cases the mortality rates exceed 40% in spite of
      adequate treatment with antimicrobials. Due to the rapid progress, the extensive damage on
      soft tissues and high risk of death, the microbes are called &quot;flesh-eating bacteria&quot;. The
      present study is a spin-off of the larger EU funded INFECT study, looking at the experiences
      of patient and family to understand the impact on every day life. The present prospective
      mixed methods study has the potential to provide important knowledge regarding the occurrence
      of early signs and symptoms of NSTI, quality of life 6 and 24 months after diagnosis, and how
      the care and treatment can be optimized and organized in a person/patient and family centered
      way. The study also aims at validate the SF 36 questionnaire for this group of patients.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of life</measure>
    <time_frame>6 months</time_frame>
    <description>Quantitative - health related quality of life Qualitative - patient experience</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quality of life</measure>
    <time_frame>24 months</time_frame>
    <description>Quantitative - health related quality of life Qualitative - patient experience</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life of significant others</measure>
    <time_frame>6 months</time_frame>
    <description>Quantitative - health related quality of life Qualitative - experience of significant others</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life of significant others</measure>
    <time_frame>24 months</time_frame>
    <description>Quantitative - health related quality of life Qualitative - experience of significant others</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Necrotizing Fasciitis</condition>
  <arm_group>
    <arm_group_label>Patients and their significant others</arm_group_label>
    <description>Patients affected by necrotizing fasciitis and their significant others</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients treated for necrotizing fasciitis at the three study sites
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients diagnosed with necrotizing fasciitis and their significant others

          -  Age above 18 yrs

        Exclusion Criteria:

          -  Persons with dementia or severe psychiatric illness

          -  Persons that do not master the Scandinavian language
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sven-Egron Thörn, MD, ass prof</last_name>
    <role>Study Director</role>
    <affiliation>Sahlgrenska University Hospital, Sweden</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Annette Erichsen Andersson, RN, PhD</last_name>
    <phone>+46737250458</phone>
    <email>annette.erichsen.andersson@gu.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ann-Mari Fagerdahl, RN, PhD</last_name>
    <phone>+46700891063</phone>
    <email>ann-mari.fagerdahl@ki.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <zip>4131</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ingrid Egerod, RN, prof</last_name>
      <email>ingrid.egerod@regionh.dk</email>
    </contact>
    <investigator>
      <last_name>Martin Bruun Madsen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sahlgrenska University hospital</name>
      <address>
        <city>Gothenburg</city>
        <zip>416 85</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sven-Egron Thörn, MD, ass prof</last_name>
      <phone>+46313434000</phone>
      <email>sven-egron.thorn@vgregion.se</email>
    </contact>
    <investigator>
      <last_name>Annette Erichsen Andersson, RN, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Karolinska Universitetssjukhuset</name>
      <address>
        <city>Solna</city>
        <zip>171 64</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Folke Lind, MD, PhD</last_name>
      <phone>+46851775557</phone>
      <email>folke.lind@karolinska.se</email>
    </contact>
    <investigator>
      <last_name>Ann-Mari Fagerdahl, RN, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
    <country>Sweden</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 19, 2014</study_first_submitted>
  <study_first_submitted_qc>June 20, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 23, 2014</study_first_posted>
  <last_update_submitted>August 11, 2017</last_update_submitted>
  <last_update_submitted_qc>August 11, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fasciitis</mesh_term>
    <mesh_term>Soft Tissue Infections</mesh_term>
    <mesh_term>Fasciitis, Necrotizing</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

